ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00048763
Recruitment Status : Completed
First Posted : November 11, 2002
Last Update Posted : July 19, 2005
Sponsor:
Information provided by:
Otsuka America Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : June 2003